Detalhe da pesquisa
1.
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1ß, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy.
Circulation
; 146(5): 372-379, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762321
2.
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Circulation
; 144(22): 1750-1759, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706555
3.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Circulation
; 144(23): 1845-1855, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710343
4.
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Circulation
; 143(1): 33-44, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148016
5.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
N Engl J Med
; 380(1): 11-22, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415628
6.
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
Circulation
; 141(5): 367-375, 2020 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707829
7.
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
Circulation
; 140(12): e673-e691, 2019 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31422671
8.
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Arterioscler Thromb Vasc Biol
; 39(2): e38-e81, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580575
9.
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
Eur Heart J
; 45(13): 1173-1176, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252107
10.
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.
Eur Heart J
; 39(27): 2526-2539, 2018 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718253
11.
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
Circulation
; 135(15): e867-e884, 2017 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28289069
12.
Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations.
Curr Atheroscler Rep
; 19(6): 29, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28500517
13.
The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
Cardiovasc Drugs Ther
; 31(2): 179-186, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28421332
14.
Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial.
J Gen Intern Med
; 31(5): 470-7, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26883526
15.
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.
Cardiovasc Drugs Ther
; 30(3): 305-13, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27240673
16.
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Eur Heart J
; 36(17): 1012-22, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25694464
17.
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
J Clin Lipidol
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664184
18.
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
Obes Pillars
; 10: 100108, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706496
19.
Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
J Am Coll Cardiol
; 83(16): 1529-1539, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530686
20.
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.
J Clin Lipidol
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565461